Header cover image

Romanian (BET) Drug Retail Industry Analysis

UpdatedDec 26, 2024
DataAggregated Company Financials
Companies2
  • 7D1.8%
  • 3M-6.5%
  • 1Y-13.0%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 3.2%, driven by declines from every company within the industry. The industry has fallen 11% in the last year.

Industry Valuation and Performance

Has the Romanian Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 26 Dec 2024RON 147.0mRON 1.9bRON 2.7m1264.6x54.9x0.08x
Sat, 23 Nov 2024RON 149.4mRON 1.9bRON 3.5m1298.3x42.3x0.08x
Mon, 21 Oct 2024RON 153.3mRON 1.9bRON 3.5m1270x43.4x0.08x
Wed, 18 Sep 2024RON 156.6mRON 1.9bRON 3.5m1263.2x44.4x0.08x
Fri, 16 Aug 2024RON 170.5mRON 1.7bRON 14.4m11.8x11.9x0.1x
Sun, 14 Jul 2024RON 170.9mRON 1.7bRON 14.4m11.8x11.9x0.1x
Tue, 11 Jun 2024RON 162.9mRON 1.7bRON 14.4m11.4x11.3x0.09x
Thu, 09 May 2024RON 161.9mRON 1.7bRON 17.2m9.4x9.4x0.1x
Sat, 06 Apr 2024RON 164.5mRON 1.7bRON 17.2m9.5x9.6x0.1x
Mon, 04 Mar 2024RON 166.5mRON 1.7bRON 17.2m9.6x9.7x0.1x
Wed, 31 Jan 2024RON 169.6mRON 1.6bRON 17.0m9.9x10x0.1x
Fri, 29 Dec 2023RON 171.0mRON 1.6bRON 17.0m10x10.1x0.1x
Sun, 26 Nov 2023RON 159.4mRON 1.6bRON 17.0m9.4x9.4x0.1x
Tue, 24 Oct 2023RON 156.5mRON 1.6bRON 15.8m10x9.9x0.1x
Thu, 21 Sep 2023RON 158.0mRON 1.6bRON 15.8m10.1x10x0.1x
Sat, 19 Aug 2023RON 160.7mRON 1.5bRON 15.0m10.8x10.7x0.1x
Mon, 17 Jul 2023RON 162.9mRON 1.5bRON 15.0m10.9x10.8x0.1x
Wed, 14 Jun 2023RON 159.0mRON 1.6bRON 14.7m10.9x10.8x0.1x
Fri, 12 May 2023RON 160.9mRON 1.5bRON 17.4m9.7x9.3x0.1x
Sun, 09 Apr 2023RON 156.2mRON 1.5bRON 17.4m9.3x9x0.1x
Tue, 07 Mar 2023RON 160.8mRON 1.5bRON 17.4m9.5x9.3x0.1x
Thu, 02 Feb 2023RON 166.2mRON 1.5bRON 17.8m9.4x9.3x0.1x
Sat, 31 Dec 2022RON 147.9mRON 1.5bRON 17.8m8.6x8.3x0.1x
Mon, 28 Nov 2022RON 153.8mRON 1.5bRON 17.8m8.8x8.6x0.1x
Wed, 26 Oct 2022RON 154.0mRON 1.5bRON 18.3m8.5x8.4x0.1x
Fri, 23 Sep 2022RON 156.9mRON 1.5bRON 18.3m8.7x8.6x0.1x
Sun, 21 Aug 2022RON 159.1mRON 1.4bRON 17.5m9.1x9.1x0.1x
Tue, 19 Jul 2022RON 169.0mRON 1.4bRON 17.6m9.6x9.6x0.1x
Thu, 16 Jun 2022RON 173.5mRON 1.4bRON 17.6m9.8x9.8x0.1x
Sat, 14 May 2022RON 166.7mRON 1.3bRON 16.7m9.8x10x0.1x
Mon, 11 Apr 2022RON 167.4mRON 1.3bRON 16.5m10x10.1x0.1x
Wed, 09 Mar 2022RON 152.7mRON 1.3bRON 16.5m9.1x9.2x0.1x
Fri, 04 Feb 2022RON 174.0mRON 1.3bRON 16.5m10.4x10.5x0.1x
Sun, 02 Jan 2022RON 172.5mRON 1.3bRON 16.5m10.3x10.4x0.1x
Price to Earnings Ratio

10.4x


Total Market Cap: RON 172.5mTotal Earnings: RON 16.5mTotal Revenue: RON 1.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Romanian Drug Retail Industry Price to Earnings3Y Average 13.7x20232024
Current Industry PE
    There are only 2 companies in the Romanian Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have declined 45% per year over the last three years.
  • Meanwhile revenues for these companies have grown 14% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Romanian Drug Retail compare with similar industries?

RO Market2.12%
Consumer Staples0.18%
Food and Staples Retail-0.47%
Drug Retail1.80%
Food Distributors0%
Food Retail0%
Big Box Super Stores0%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RPH S.C. RopharmaRON 0.172.4%
+RON 2.0m
-16.5%PE2506.8x
RMAH Farmaceutica REMEDIARON 0.640.9%
+RON 553.9k
-7.2%PE22.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.